Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00449787 · ClinicalTrials.gov registry record · Phase 4
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 401
- Enrollment target
NCT00449787 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 401 participants.
The verdict
NCT00449787, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 401 participants
- Enrollment target
Study Summary
2/3 of patients discharged from an emergency department after treatment for an acute headache will still be bothered by headache within 24 hours of emergency department (ED) treatment. The goal of this study is to compare two medications, naproxen and sumatriptan, to determine which is better for the treatment of recurrent headache within 24 hours of emergency department discharge.
Interventions
- DRUG Naproxen
- DRUG Sumatriptan 100 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00449787
The ClinicalTrials.gov registry entry for NCT00449787 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 401 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Naproxen is the first listed.
NCT00449787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00449787 about?
NCT00449787 is a clinical study titled "Comparing Naproxen to Sumatriptan for Emergency Headache Patients". 2/3 of patients discharged from an emergency department after treatment for an acute headache will still be bothered by headache within 24 hours of emergency department (ED) treatment. The goal of this study is to compare two medications, naproxen and sumatriptan, to determine which is better for th...
What is the current status of trial NCT00449787?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 401 participants. The study started on 2007-03. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00449787?
The interventions under investigation include: Naproxen (DRUG), Sumatriptan 100 mg (DRUG).
Who is sponsoring clinical trial NCT00449787?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.